Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been referred by their doctor for a standard PET scan as part of their usual medical care, for one of the conditions covered by this trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are not willing to avoid unusual, unaccustomed, or strenuous physical activity starting 4 days before the scan tracer injection and until 1 day after the injection.
- People who do not understand what the study involves.
- People who are unwilling or unable to complete all study procedures, or who the lead doctor considers unsuitable for any reason.
- People who have been exposed to ionizing radiation (more than 1 mSv) as part of another research study within the past 12 months.
- People who do not agree to have any unexpected findings shared with their general practitioner and with themselves.
- People who are not able to give their own consent (this applies particularly to certain sub-studies involving neurodegeneration conditions).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Difference in diagnostic accuracy and/or diagnostic confidence of ultra-high resolution PET/CT compared to standard PET/CT and validated against clinical follow-up, or pathological/surgical outcomes in neurodegenerative disorders.; Difference in diagnostic accuracy and/or diagnostic confidence of ultra-high resolution PET/CT compared to standard PET/CT and validated against clinical follow-up, or pathological/surgical outcomes in head and neck cancer.; Comparison of the sensitivity, specificity and accuracy of ultra-high resolution PET vs. standard-of-care PET for the diagnosis of vasculitis a...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.